Literature DB >> 16051947

Persistence of restrictions in quality of life from the first to the third year after diagnosis in women with breast cancer.

Volker Arndt1, Henrike Merx, Christa Stegmaier, Hartwig Ziegler, Hermann Brenner.   

Abstract

PURPOSE: To assess whether detriments in quality of life (QOL) among women with breast cancer persist over years. PATIENTS AND METHODS: QOL was assessed in a population-based cohort of 314 women with breast cancer from Saarland (Germany) 1 and 3 years after diagnosis and compared internally and with reference data from the general population.
RESULTS: Three years after diagnosis, deficits in QOL were still apparent for role, emotional, cognitive, and social functioning and for the symptoms of insomnia, fatigue, dyspnea, and financial difficulties. Differences between breast cancer patients and women from the general population were predominantly found in younger ages. Compared with the QOL scores measured 1 year after diagnosis, only minor functional changes were observed, but recurrence of breast cancer during the follow-up interval had a deleterious effect on QOL.
CONCLUSION: Deficits in role, emotional, cognitive, and social functioning persist over years in women with breast cancer and predominantly affect younger patients.

Entities:  

Mesh:

Year:  2005        PMID: 16051947     DOI: 10.1200/JCO.2005.03.475

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  46 in total

1.  Cancer survivors' responses to daily stressors: implications for quality of life.

Authors:  Erin S Costanzo; Robert S Stawski; Carol D Ryff; Christopher L Coe; David M Almeida
Journal:  Health Psychol       Date:  2012-01-23       Impact factor: 4.267

2.  Psychological impact of thrombosis in the young.

Authors:  Diletta Fiandaca; Paolo Bucciarelli; Ida Martinelli; Francesca Tantardini; Carmen Clemente; Pier Mannuccio Mannucci
Journal:  Intern Emerg Med       Date:  2006       Impact factor: 3.397

Review 3.  Impact on quality of life of adjuvant therapy for breast cancer.

Authors:  Halle C F Moore
Journal:  Curr Oncol Rep       Date:  2007-01       Impact factor: 5.075

4.  Ethnicity and spirituality in breast cancer survivors.

Authors:  Ellen G Levine; Grace Yoo; Caryn Aviv; Cheryl Ewing; Alfred Au
Journal:  J Cancer Surviv       Date:  2007-09       Impact factor: 4.442

5.  Using Anchoring Vignettes in the Evaluation of Breast Cancer Survivors' Quality of Life.

Authors:  Andreas Hinz
Journal:  Breast Care (Basel)       Date:  2017-02-08       Impact factor: 2.860

6.  Factors affecting health-related quality of life in women with recurrent breast cancer in Korea.

Authors:  Myung Kyung Lee; Byung Ho Son; Sook Yeon Hwang; Wonshik Han; Jung-Hyun Yang; Seeyoun Lee; Young Ho Yun
Journal:  Qual Life Res       Date:  2007-02-06       Impact factor: 4.147

7.  Prevalence and frequency of self-management strategies among female cancer survivors: the neglected roles of social relations and conscious living.

Authors:  Monika Sieverding; Nadine Ungar; Alexandra Fleischmann; Miruh Lee; Haitong Zhang; Margaux Mohnke; Nicole K Specht; Gerdi Weidner
Journal:  Support Care Cancer       Date:  2019-05-18       Impact factor: 3.603

8.  Quality of life of women treated with radiotherapy for breast cancer.

Authors:  T S Lee; S L Kilbreath; K M Refshauge; S C Pendlebury; J M Beith; M J Lee
Journal:  Support Care Cancer       Date:  2007-09-18       Impact factor: 3.603

9.  Psychosocial adjustment among cancer survivors: findings from a national survey of health and well-being.

Authors:  Erin S Costanzo; Carol D Ryff; Burton H Singer
Journal:  Health Psychol       Date:  2009-03       Impact factor: 4.267

10.  A high protein moderate carbohydrate diet fed at discrete meals reduces early progression of N-methyl-N-nitrosourea-induced breast tumorigenesis in rats.

Authors:  Christopher J Moulton; Rudy J Valentine; Donald K Layman; Suzanne Devkota; Keith W Singletary; Matthew A Wallig; Sharon M Donovan
Journal:  Nutr Metab (Lond)       Date:  2010-01-10       Impact factor: 4.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.